Mintz advised QIAGEN on the deal. QIAGEN N.V. announced its $150 million completed acquisition of Verogen, a leader in the use of next-generation sequencing technologies to drive...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here